S034 Late-Breaking Research: Session 2
DESCRIPTION
The Late Breaking Abstract Sessions showcase the most timely, high-impact, and unpublished research across the full spectrum of dermatology. Through a rigorous peer-review process, top-scoring submissions are selected for concise oral presentations that emphasize novelty and clinical relevance. This session features practice-changing clinical trials, population-based investigations, transformative technologies, translational biomarker studies, and innovative basic science. Abstracts addressing skin, hair, and nail disorders will be highlighted, with particular emphasis on discoveries that deepen understanding of disease mechanisms, inform therapeutic development, or improve the prevention and management of adverse events.
LEARNING OBJECTIVES
Evaluate late-breaking clinical, translational, and basic science studies for scientific rigor, novelty, and relevance to advancing dermatologic disease mechanisms and therapy.
Apply emerging evidence from trials, population studies, and biomarkers to improve clinical decision-making, patient outcomes, and prevention of adverse events.
Identify how novel discoveries and technologies impact dermatologic practice and healthcare systems, including implications for prevention, risk stratification, and multidisciplinary care.
SCHEDULE
1:00 PM
Concomitant therapy with ixekizumab plus tirzepatide in adults with psoriatic arthritis and overweight or obesity demonstrated superior disease control compared to ixekizumab alone: results from the Ph3b TOGETHER-PsA trial
Joseph Merola, MD, MSc, FAAD
1:12 PM
Targeting IL-15 with ordesekimab depletes cytotoxic CD8+ memory T cells and, in combination with phototherapy, results in greater repigmentation of vitiligo compared to placebo
Brett King, MD, PhD, FAAD
1:24 PM
Once-daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Melinda Gooderham, MD, FAAD
1:36 PM
Integrative Transcriptomic Profiling Identifies a Dominant Macrophage-Derived IL-1ß/NLRP3 Inflammasome Axis in Hidradenitis Suppurativa
Andrea Daamen
1:48 PM
Povorcitinib in Patients With Moderate to Severe Hidradenitis Suppurativa: 54-Week Efficacy and Safety Results From the STOP-HS1 & STOP-HS2 Phase 3 Studies
Martina J. Porter, MD, FAAD
2:00 PM
Sonelokimab in moderate-to-severe HS: Long-term results through Week 40 of two Phase 3 trials
Alexandra Boer Kimball, MD, MPH, FAAD
2:24 PM
Vilobelimab Treatment for Ulcerative Pyoderma Gangrenosum: Results from a Multicenter, Randomized, Placebo Controlled Phase 3 Trial
Benjamin Kaffenberger, MD, MS, FAAD
2:36 PM
Diagnostic Performance of a Skin Cancer Detection AI Medical Device: A Prospective Clinical Validation Study and Repeatability and Reproducibility of a Skin Cancer Detection AI Medical Device: A Diagnostic Study
Helen Marsden
2:48 PM
Efficacy and Mechanistic Insights of 1565 nm Fractional Non-Ablative Laser Therapy in Androgenetic Alopecia: A Prospective, Randomized Clinical and Histologic Study
Neil S. Sadick, MD, FAAD
3:00 PM
PD-1 Directed Intratumoral Immunotherapy: Results of an Escalating Dose Study of INTASYL PH-762 for Cutaneous Carcinomas
Mary C. Spellman, MD, FAAD
3:12 PM
Results of a Multicenter, Randomized, Double-Blind, Controlled Phase ? Study of LP-003 Injection in H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU)
Xing-Hua Gao, MD, PhD
3:24 PM
Efficacy and Safety of Litifilimab in Cutaneous Lupus Erythematosus (CLE): 24-week results of the Phase 2 Study, AMETHYST Part A
Victoria P. Werth, MD, FAAD
3:36 PM
Brepocitinib Achieves Rapid and Sustained Control of Cutaneous Disease Activity, Itch, and Skin-Related Quality of Life in Dermatomyositis: Results From the Phase 3 VALOR Trial
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
3:48 PM
Dupilumab Reduces Keloid Dimensions and Halts Fibrosis
Jerry Zhou
DIRECTOR
Hensin Tsao, MD, PhD, FAAD
MODERATORS
Murad Alam, MD, MSCI, MBA, FAAD
Northwestern University
April W. Armstrong, MD, MPH, FAAD
University of California Los Angeles
Aaron Mark Drucker, MD, FAAD
Joel M. Gelfand, MD, MSCE, FAAD
Kenneth B. Gordon, MD, FAAD
Sewon Kang, MD, FAAD
Paul Nghiem, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Sandy Sharon Tsao, MD, FAAD
SPEAKERS
Andrea Daamen
Xing-Hua Gao, MD, PhD
The First Hospital of China Medical University
Melinda Gooderham, MD, FAAD
SKiN Centre for Dermatology/ Queen’s University
Benjamin Kaffenberger, MD, MS, FAAD
Alexandra Boer Kimball, MD, MPH, FAAD
Harvard Medical School and Beth Israel Deaconess Medical Center
Brett King, MD, PhD, FAAD
Helen Marsden
Skin Analytics Ltd
Joseph Merola, MD, MSc, FAAD
Martina J. Porter, MD, FAAD
Beth Israel Deaconess Medical Center & Harvard Medical School
Neil S. Sadick, MD, FAAD
Mary C. Spellman, MD, FAAD
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
Mass General Brigham
Victoria P. Werth, MD, FAAD
Jerry Zhou
DISCLOSURES
Murad Alam, MD, MSCI, MBA, FAAD
No financial relationships exist with ineligible companies.
April W. Armstrong, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Consultant(Honoraria); Boehringer Ingelheim – Data Safety Monitoring Board(Honoraria); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant(Honoraria); Dermsquared – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Andrea Daamen
No financial relationships exist with ineligible companies.
Aaron Mark Drucker, MD, FAAD
No financial relationships exist with ineligible companies.
Xing-Hua Gao, MD, PhD
No financial relationships exist with ineligible companies.
Joel M. Gelfand, MD, MSCE, FAAD
AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);
Melinda Gooderham, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Acelyrin – Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Aristea Therapeutics – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Bausch Health – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Dermavant Sciences – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma Laboratories, LP – Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Inmagene Biopharmaceuticals – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc. – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Reistone Biopharma – Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Tarsus – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Ventyx Biosciences – Investigator(Grants/Research Funding); VYNE Therapeutics – Investigator(Grants/Research Funding);
Kenneth B. Gordon, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);
Benjamin Kaffenberger, MD, MS, FAAD
Almirall – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Leo Pharma – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria);
Sewon Kang, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Estee Lauder – Advisory Board(Honoraria); Galderma USA – Advisory Board(Honoraria); Incyte Corporation – Data Safety Monitoring Board(Fees); Rapalogix Health – Advisory Board(Stock Options); Walgreens Boots Alliance, Inc. – Investigator(Grants/Research Funding);
Alexandra Boer Kimball, MD, MPH, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Acelyrin – Investigator(Grants/Research Funding); Almirall – Board of Directors(Fees), Consultant(Honoraria); AnaptysBio – Investigator(Grants/Research Funding); Avalo Therapeutics Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); BMS – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Cellarity – Consultant (1099 relationship)(Fees); Citryll – Consultant (1099 relationship)(Fees); Curogen – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Incyte – Investigator(Grants/Research Funding); Incyte Corporation – Consultant (1099 relationship)(Fees); Innovaderm Research Inc. – Speaker(Honoraria); Insmed Incorporated – Investigator(Grants/Research Funding); Janssen Biotech – Consultant(Honoraria); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Fees); Moonlake – Consultant(Fees), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Nurix – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Investigator(Other Financial Benefit); Regeneron Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Sanofi – Consultant(Honoraria), Investigator(Fees); Sonoma Bio – Consultant(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees); Target RWE – Advisory Board(Fees); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding); UCSD – Advisory Board(Honoraria); Union Therapeutics – Consultant (1099 relationship)(Fees); Ventyx Biosciences – Consultant(Fees), Consultant(Stock Options); Zura Bio – Consultant (1099 relationship)(Fees);
Brett King, MD, PhD, FAAD
AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); Amgen – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Aquestive Therapeutics – Consultant (1099 relationship)(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Galderma – Advisory Board(Honoraria); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Leo Pharma – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees); Regeneron – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Sanofi Genzyme – Speaker(Honoraria); Soterios Pharma – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant(Fees), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);
Helen Marsden
Skin Analytics Limited – Employee – Lab does sell products(Salary), Employee – Lab does sell products(Stock), Employee – Lab does sell products(Stock Options);
Joseph Merola, MD, MSc, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Consultant(Honoraria); Galderma – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Fees); Sanofi/Regeneron – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria);
Paul Nghiem, MD, PhD, FAAD
Almirall – Consultant(Honoraria); Bristol-Myers Squibb – Investigator(Grants/Research Funding); EMD Serono – Consultant(Fees); Merck & Co., Inc – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Martina J. Porter, MD, FAAD
AbbVie – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Alumis – Consultant(Fees); AnaptysBio – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bayer – Investigator(Grants/Research Funding); Beth Israel Deaconess Medical Center – Other(Patent royalties or other compensation for Intellectual Property Rights); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(No Compensation Received); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Consultant(Fees); Merck – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Mirador – Investigator(Grants/Research Funding); Moonlake – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Consultant(Fees), Investigator(Grants/Research Funding); Oasis Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Prometheus Laboratories, Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sonoma Biotherapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Trifecta Clinical – Consultant(Fees); UCB – Consultant(Fees), Investigator(Grants/Research Funding); Zura Bio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Neil S. Sadick, MD, FAAD
AbbVie – Consultant(Fees); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Acorn Biolabs – Speaker(Honoraria); Advalight – Investigator(Grants/Research Funding), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Alma Lasers, Inc. – Investigator(Equipment), Investigator(Grants/Research Funding); American Academy of Dermatology – Speaker(No Compensation Received); American Hair Research Society – Board of Directors(No Compensation Received); American Society of Dermatologic Surgery – Speaker(No Compensation Received); Amgen – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Aurigene Discovery Technologies Ltd – Independent Contractor(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bellus Health – Investigator(Grants/Research Funding); Biorasi, LLC – Investigator(Grants/Research Funding); Biosion – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Other(Equipment); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cell Research Corp – Consultant (1099 relationship)(Honoraria); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Other(Equipment), Speaker(Honoraria); Derm Advance – Stockholder(Stock Options); Derm Tech International – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Distinct Dermatology – Stockholder Private Company(Stock Options); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); EndyMed Medical Inc. USA – Speaker(Honoraria); Fortrea – Investigator(No Compensation Received); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Galderma USA – Investigator(Grants/Research Funding); Gerson Lehrman Group – Consultant(Honoraria); GlaxoSmithKline Immunology – Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); ICON plc. – Investigator(No Compensation Received); IMCAS – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Other Financial Benefit); Incyte Corporation – Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); Innovaderm Research Inc. – Investigator(No Compensation Received); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Kimera Labs, Inc – Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); LCN Consulting – Consultant(Fees); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant(Fees), Investigator(Grants/Research Funding); Lumisque – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Investigator(Grants/Research Funding); Paraxel Therapeutics, Inc – Investigator(No Compensation Received); Pfizer Inc. – Investigator(Grants/Research Funding); PPD Inc. – Investigator(Grants/Research Funding); Rho Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Equipment), Investigator(Grants/Research Funding); Scientus Pharma Inc. – Stockholder(Stock Options); Shaperon – Investigator(Equipment), Investigator(Grants/Research Funding); Syneos Health – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Taylor & Francis – Other(Other Financial Benefit); UCB – Investigator(Equipment), Investigator(Grants/Research Funding); Union Therapeutics – Investigator(Grants/Research Funding); Venus Concept – Investigator(Grants/Research Funding), Other(Equipment), Stockholder(Stock Options); VeraDermics Inc. – Investigator(Grants/Research Funding); Vial – Investigator(No Compensation Received); Vydence Medical – Other(Equipment), Speaker(Honoraria); WeThrivv – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Stock Options);
Mary C. Spellman, MD, FAAD
Azitra Inc – Consultant (1099 relationship)(Other Financial Benefit); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Other Financial Benefit); Phio Pharmaceuticals Inc – Consultant (1099 relationship)(Other Financial Benefit); Rubedo Life Sciences – Consultant (1099 relationship)(Other Financial Benefit);
Hensin Tsao, MD, PhD, FAAD
Epiphany Dermatology – Advisory Board(Honoraria), Advisory Board(Stock Options); Massachusetts General Hospital – Employee(Salary); UpToDate, Inc. – Other(Honoraria);
Sandy Sharon Tsao, MD, FAAD
Beiersdorf, Inc. – Consultant (1099 relationship)(Honoraria); Epiphany Dermatology – Advisory Board(Stock); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);
Jerry Zhou
No financial relationships exist with ineligible companies.